- US-listed companies
- Inspire Medical Systems, Inc.
- Income statement
Inspire Medical Systems, Inc. (INSP) Income statement
Market cap
$1.2B
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 51 | 82 | 115 | 233 | 408 | 625 | 803 |
| Revenue growth (%) | - | ||||||
| Cost of revenue | 10 | 14 | 18 | 33 | 66 | 97 | 123 |
| Gross profit | 41 | 68 | 98 | 200 | 342 | 528 | 680 |
| Gross margin (%) | |||||||
| Research & development | 7 | 13 | 26 | 37 | 69 | 117 | 114 |
| Selling, general & administrative | 54 | 90 | 128 | 203 | 321 | 452 | 530 |
| Operating margin (%) | |||||||
| Operating expenses | 61 | 103 | 154 | 240 | 389 | 568 | - |
| Operating income | -20 | -35 | -56 | -40 | -48 | -40 | 36 |
| Income before tax | -22 | -33 | -57 | -42 | -44 | -20 | 58 |
| Pretax margin (%) | -43.1 | -40.5 | -49.5 | -18 | -10.9 | -3.2 | 7.3 |
| Provision for income taxes | - | 0 | 0 | 0 | 1 | 1 | 5 |
| Effective tax rate (%) | - | ||||||
| Net income | -22 | -33 | -57 | -42 | -45 | -21 | 54 |
| Net income margin (%) | |||||||
| Earnings per share | - | - | - | -1.54 | -1.6 | -0.72 | 1.8 |
| Diluted EPS | - | - | - | -1.54 | -1.6 | -0.72 | 1.75 |
| EBITDA | |||||||
| EBITDA margin (%) |